Cancer incidence among persons with fragile X syndrome in Finland: a population-based study.
Fragile X syndrome does not raise overall cancer risk; just watch lips and teeth.
01Research in Context
What this study did
Lawer et al. (2009) checked cancer records for every person with fragile X syndrome in Finland.
They counted new cancers and compared the rate to the general public.
What they found
Cancer risk was the same as everyone else.
Only lip cancer showed a small bump, but that single signal could be chance.
Fragile X does not act like a shield against tumors.
How this fits with other research
do Amaral et al. (2024) extends the health watch list: fragile X patients also have more cavities and stronger cavity-causing bacteria.
Together the two papers say, "Watch teeth and lips, but don’t expect rare cancers."
Alanay et al. (2007) and Berry-Kravis et al. (2010) already mapped heart, ear, eye, and seizure issues; Lawer et al. (2009) now adds cancer to the same full-body checklist.
The picture is one of scattered, mild medical risks, not one big cancer spike.
Why it matters
You can tell families the data so far show no extra cancer worry.
Keep doing routine screenings you already use.
Add a quick lip exam at annual check-ups and remind parents about dental visits—those two spots show the clearest signals so far.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add "lip and mouth check" to the nurse consultation form you hand to parents once a year.
02At a glance
03Original abstract
BACKGROUND: Fragile X syndrome is a common inheritable cause of intellectual disability (ID) and is characterised by a large number of CGG repeats at the gene FMR1 located on the X-chromosome. It has been reported that this genetic mechanism may protect against malignant transformations. METHODS: We extracted from the Finnish registry on persons with ID a cohort of 302 persons with a fragile X diagnosis during 1982-1986. Follow-up for cancer incidence was performed in the Finnish Cancer Registry until the end of the year 2005. RESULTS: There were 11 reported cancers during the mean follow-up of 21.4 years per person. The expected number of cancers based on the average Finnish population was 13.8 and no statistically significant protective effect was detected [standardised incidence ratios (SIR) 0.80, confidence interval (CI) 95% 0.40-1.4]. An increased risk for lip cancer was found (SIR 23, CI 95% 2.8-85). CONCLUSIONS: Confirmation of hypotheses about the mechanisms linking FXS and cancer needs further research.
Journal of intellectual disability research : JIDR, 2009 · doi:10.1111/j.1365-2788.2008.01116.x